Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.62 |
| ▸ | LMNA | P02545 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | RAB9A | P51151 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.51 |
| ▸ | METAP1 | P53582 | 1/20 | 0.47 |
| ▸ | TDP2 | O95551 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | CASP7 | P55210 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL123584 | 0.87 | RAB9A (0.78) | MAPTLMNAALDH1A1RAB9AKDM4E | |
| SCHEMBL29372630 | 0.87 | RAB9A (0.78) | MAPTLMNAALDH1A1RAB9AKDM4E | |
| SCHEMBL29376113 | 0.87 | METAP1 (0.57) | MAPTLMNAALDH1A1RAB9AKDM4E | |
| SCHEMBL40823 | 0.87 | METAP1 (0.57) | MAPTLMNAALDH1A1RAB9AKDM4E | |
| SCHEMBL28126153 | 0.87 | METAP1 (0.57) | MAPTLMNAALDH1A1RAB9AKDM4E | |
| Ammonia Solution, Strong SCHEMBL28144371 | 0.84 | METAP1 (0.55) | MAPTLMNAALDH1A1RAB9AKDM4E | |
| SCHEMBL27619851 | 0.84 | METAP1 (0.55) | MAPTLMNAALDH1A1RAB9AKDM4E | |
| Hydrochloric Acid SCHEMBL867181 | 0.84 | RAB9A (0.75) | MAPTLMNAALDH1A1RAB9AKDM4E | |
| Hydrochloric Acid SCHEMBL17417855 | 0.84 | RAB9A (0.75) | MAPTLMNAALDH1A1RAB9AKDM4E | |
| Hydrochloric Acid SCHEMBL30705049 | 0.84 | RAB9A (0.75) | MAPTLMNAALDH1A1RAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105037167-B | A kind of synthetic method of N, N diaryl 2 bromine 6 naphthylamines and its application | 华南理工大学 | 2017-03-01 | — | — | CN | claimed |
| CN-105037167-A | Synthetic method of N, N-diaryl-2-bromine-6-naphthylamine and application thereof | UNIV SOUTH CHINA TECH | 2015-11-11 | — | — | CN | claimed |
| CN-104762477-A | Method for recovering and treating waste containing silver component | CHEN YIWEN | 2015-07-08 | — | — | CN | claimed |
| US-5663030-A | A PHENYL OR NORBORNANE DERIVATIVE AS AN ADDITIVE TO REDUCE HEAT AND ENERGY REQUIRED TO FUSE THE TONER AND TO REDUCE JAMMING OF THE EQUIPMENT | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| WO-1993014062-A1 | ANTHELMINTIC β-KETOAMIDES | THE UPJOHN COMPANY (US) | 1993-07-22 | — | — | WO | claimed |
| EP-4440312-A1 | INSECT NEUROPEPTIDE ANALOGUES | Solasta Bio Limited (GB) | 2024-10-09 | — | — | EP | disclosed |
| US-11806335-B2 | Heterocyclic carboxylate compounds as glycolate oxidase inhibitors | Lilac Therapeutics, Inc. (US) | 2023-11-07 | — | — | US | disclosed |
| US-11806335-B2 | Heterocyclic carboxylate compounds as glycolate oxidase inhibitors | Lilac Therapeutics, Inc. (US) | 2023-11-07 | — | — | US | disclosed |
| WO-2023099922-A1 | INSECT NEUROPEPTIDE ANALOGUES | Solasta Bio Limited (GB) | 2023-06-08 | — | — | WO | disclosed |
| WO-2023099922-A1 | INSECT NEUROPEPTIDE ANALOGUES | Solasta Bio Limited (GB) | 2023-06-08 | — | — | WO | disclosed |
| CN-105973472-B | A kind of near-infrared fluorescent temperature sensing method and material | 北京大学 | 2019-02-22 | — | — | CN | disclosed |
| CN-105037167-B | A kind of synthetic method of N, N diaryl 2 bromine 6 naphthylamines and its application | 华南理工大学 | 2017-03-01 | — | — | CN | disclosed |
| US-5670564-A | Macromonomers having reactive end groups | MAXDEM INCORPORATED (US) | 1997-09-23 | — | — | US | disclosed |
| EP-0793643-A1 | MATRIX METALLOPROTEASE INHIBITORS | SYNTEX (U.S.A.) INC. (US) | 1997-09-10 | — | — | EP | disclosed |
| EP-0599886-A4 | MACROMONOMERS HAVING REACTIVE END GROUPS. | MAXDEM INC (US) | 1996-07-24 | — | — | EP | disclosed |
| WO-1996016027-A1 | MATRIX METALLOPROTEASE INHIBITORS | SYNTEX (U.S.A.) INC. (US) | 1996-05-30 | — | — | WO | disclosed |
| EP-0599886-A1 | MACROMONOMERS HAVING REACTIVE END GROUPS | MAXDEM INCORPORATED (US) | 1994-06-08 | — | — | EP | disclosed |
| US-5230998-A | Viricides | AIDA DEVELOPMENT CORPORATION | 1993-07-27 | — | — | US | disclosed |
| WO-1993014062-A1 | ANTHELMINTIC β-KETOAMIDES | THE UPJOHN COMPANY (US) | 1993-07-22 | — | — | WO | disclosed |
| WO-1993004099-A1 | MACROMONOMERS HAVING REACTIVE END GROUPS | MAXDEM INCORPORATED (US) | 1993-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11806335-B2 | Heterocyclic carboxylate compounds as glycolate oxidase inhibitors | UGDH, PGD, PNPO | MAPT 3488/4885LMNA 4767/4885ALDH1A1 184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.